United States of America based
Menten is a biotech startup developing a software platform for protein design empowered by machine learning and quantum computing. Menten’s quantum approach aims to overcome the scalability challenges that limit classical methods in computational protein design to significantly improve accuracy and reduce development time. Menten’s goal is to create the computational tools required to deliver on the promise of protein-based medicine and biocatalysis.
quantum computing protein design
TechnologiesAI Companies (Drug Discovery) Quantum Theory in Drug Discovery
Posts Mentioning This Company
By taking a hybrid quantum-classical computing approach using D-Wave’s 2000Q quantum system, Menten hopes to be able to significantly reduce the cost and time required to engineer proteins for drug design, as well as overcome the scalability challenges that limit classical approaches. The hybrid approach has already resulted in better solutions, faster
No pipelines published yet